仙乐健康
(300791)
| 流通市值：65.03亿 | | | 总市值：77.99亿 |
| 流通股本：2.57亿 | | | 总股本：3.08亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,291,173,866.65 | 2,041,618,895.92 | 954,215,143.94 | 4,211,063,837.44 |
| 营业收入 | 3,291,173,866.65 | 2,041,618,895.92 | 954,215,143.94 | 4,211,063,837.44 |
| 二、营业总成本 | 3,046,438,602.78 | 1,891,846,695.56 | 898,981,704.9 | 3,893,466,402.02 |
| 营业成本 | 2,229,386,326.65 | 1,364,132,984.92 | 638,474,070.68 | 2,886,115,370.63 |
| 税金及附加 | 18,515,045.78 | 12,337,199.24 | 7,021,809.14 | 30,988,859.09 |
| 销售费用 | 273,442,676.89 | 176,929,539.18 | 89,015,123.73 | 353,203,965.03 |
| 管理费用 | 353,487,534.88 | 234,162,088.13 | 113,101,656.37 | 417,653,783.45 |
| 研发费用 | 100,513,939.25 | 62,163,531.68 | 29,103,485.1 | 125,936,900.67 |
| 财务费用 | 71,093,079.33 | 42,121,352.41 | 22,265,559.88 | 79,567,523.15 |
| 其中:利息费用 | 75,661,830.72 | 48,942,604.97 | 24,381,436.39 | 78,740,403.11 |
| 其中:利息收入 | 5,366,923.52 | 3,526,812.73 | 1,989,281.21 | 6,887,671.12 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,361,713.44 | 1,360,617.55 | 1,556,373.71 | -21,948,964.43 |
| 加:投资收益 | -2,178,133.11 | 355,524.37 | 868,057.54 | -4,773,162.22 |
| 资产处置收益 | 360,551.26 | -26,644.23 | -1,477.05 | 243,157.15 |
| 资产减值损失(新) | -9,215,691.68 | -8,278,945.26 | 663,643.78 | -5,104,504.94 |
| 信用减值损失(新) | -3,225,272.89 | 216,417.72 | 1,879,211.35 | -913,727.34 |
| 其他收益 | 28,960,516.24 | 8,002,839.4 | 4,729,435.23 | 41,907,052.51 |
| 四、营业利润 | 260,798,947.13 | 151,402,009.91 | 64,928,683.6 | 327,007,286.15 |
| 加:营业外收入 | 658,701.28 | 1,962,544.19 | 1,858,114.33 | 1,930,391.43 |
| 减:营业外支出 | 6,501,829.68 | 4,810,969.93 | 1,926,963.23 | 12,283,569.81 |
| 五、利润总额 | 254,955,818.73 | 148,553,584.17 | 64,859,834.7 | 316,654,107.77 |
| 减:所得税费用 | 33,122,608.71 | 12,293,566.25 | 8,372,769.79 | 34,636,187.55 |
| 六、净利润 | 221,833,210.02 | 136,260,017.92 | 56,487,064.91 | 282,017,920.22 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 221,833,210.02 | 136,260,017.92 | 56,487,064.91 | 282,017,920.22 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 260,267,463.38 | 161,117,310.35 | 68,640,679.6 | 325,061,746.98 |
| 少数股东损益 | -38,434,253.36 | -24,857,292.43 | -12,153,614.69 | -43,043,826.76 |
| 扣除非经常损益后的净利润 | 244,445,836.24 | 159,488,146.1 | 65,065,152.27 | 327,731,789.61 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.85 | 0.53 | 0.29 | 1.39 |
| (二)稀释每股收益 | 0.85 | 0.53 | 0.29 | 1.39 |
| 八、其他综合收益 | 28,290,303.01 | 31,139,887.11 | 13,655,659.94 | -6,220,745.56 |
| 归属于母公司股东的其他综合收益 | 29,596,272.09 | 31,627,258.47 | 13,847,749.98 | -8,492,424.25 |
| 九、综合收益总额 | 250,123,513.03 | 167,399,905.03 | 70,142,724.85 | 275,797,174.66 |
| 归属于母公司股东的综合收益总额 | 289,863,735.47 | 192,744,568.82 | 82,488,429.58 | 316,569,322.73 |
| 归属于少数股东的综合收益总额 | -39,740,222.44 | -25,344,663.79 | -12,345,704.73 | -40,772,148.07 |
| 公告日期 | 2025-10-29 | 2025-08-26 | 2025-04-24 | 2025-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |